Ask to take part

Contact the study team using the details below to take part. If there are no contact details below please ask your doctor in the first instance.

Contact Information:

Study Location:

Find another location


Questions to ask
Skip to Main Content
English | Cymraeg
Be Part of Research - Trial Details - A Study of IMM-101 in Combination With Radiation Induced Tumour Necrosis in Colorectal Cancer
Back

A Study of IMM-101 in Combination With Radiation Induced Tumour Necrosis in Colorectal Cancer

Completed

Open to: ALL

Age: 18.0 - N/A

London London

Medical Conditions

Colorectal Neoplasms
Necrosis

This information is provided directly by researchers, and we recognise that it isn't always easy to understand. We are working with researchers to improve the accessibility of this information. In some summaries, you may come across links to external websites. These websites will have more information to help you better understand the study.


The purpose of this study is to investigate the safety and effects of IMM 101 in combination with a single targeted dose of radiation in patients with metastatic colorectal cancer in whom chemotherapy or other treatment has not been effective. Administration of radiation (using the CyberKnife) to the target tumour growth in the liver results in the release of tumour material. IMM-101 may help the immune system to react to the tumour material released from the damaged tumour, and so have a beneficial effect in slowing down the rate of growth of other tumour growths in the liver and other organs.

Start dates may differ between countries and research sites. The research team are responsible for keeping the information up-to-date.  

The recruitment start and end dates are as follows:

Feb 2012 Aug 2014

INTERVENTIONAL

Intervention Type : BIOLOGICAL
Intervention Description : IMM-101 is a suspension of heat-killed whole cell M. obuense in borate-buffered saline.

Intervention Arm Group : IMM-101 plus SBRT;

Intervention Type : RADIATION
Intervention Description : The CyberKnife system is normally used for the treatment of cancerous tumours in cases where the type and position of the tumour and the condition of the patient indicate that treatment may be curative. In this study, the CyberKnife is being used in an experimental way to deliver a targeted dose of stereotactic body radiation with extreme accuracy in order to damage a single tumour growth (metastasis) in the liver.

Intervention Arm Group : IMM-101 plus SBRT;



You can take part if:



You may not be able to take part if:


This is in the inclusion criteria above


Below are the locations for where you can take part in the trial. Please note that not all sites may be open.

  • The London Clinic
    London
  • HCA International, The Sarah Cannon Research Institute
    London
    W1G 6AD


The study is sponsored by Immodulon Therapeutics Ltd



We'd like your feedback

Your feedback is important to us. It will help us improve the quality of the study information on this site. Please answer both questions.


Is this study information helpful?

What will you do next?
Read full details for Trial ID: NCT01539824
Last updated 01 December 2016

This page is to help you find out about a research study and if you may be able to take part

You can print or share the study information with your GP/healthcare provider or contact the research team directly.   

Back to the top